SCHEMBL138234

SCHEMBL138234

O=C1C=CC(=O)N1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL157324 0.67 MGLL (0.50)
SCHEMBL8723029 0.67
SCHEMBL22214505 0.65
SCHEMBL11704366 0.62 MGLL (0.39)
SCHEMBL4813241 0.62
SCHEMBL10586150 0.62 MGLL (0.38)
SCHEMBL16104380 0.61
SCHEMBL8135505 0.61
SCHEMBL6045734 0.61
SCHEMBL718436 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4341315-A1 IMIDAZOLIUM-BASED POLY(IONIC LIQUID)S AND USE THEREFORE Versum Materials US, LLC (US) 2024-03-27 EP claimed
CN-109289094-B Intravascular stent material and preparation method thereof 湖南博隽生物医药有限公司 2021-11-02 CN claimed
CN-112336917-A Degradable implantation type blood vessel support 湖南博隽生物医药有限公司 2021-02-09 CN claimed
CN-112274706-A Intravascular stent material 湖南博隽生物医药有限公司 2021-01-29 CN claimed
CN-103565802-B Application of N-(3, 5-dichlorophenyl)-3, 4-dichloro-maleimide in fungal infection resistance UNIV ZHEJIANG TECHNOLOGY 2015-06-03 CN claimed
EP-2804900-A1 SYNTHESIZED RESINS AND VARNISHES, PREPREGS AND LAMINATES MADE THEREFROM Isola USA Corp. (US) 2014-11-26 EP claimed
CN-103565802-A Application of N-(3, 5-dichlorophenyl)-3, 4-dichloro-maleimide in fungal infection resistance UNIV ZHEJIANG TECHNOLOGY 2014-02-12 CN claimed
WO-2013110068-A1 SYNTHESIZED RESINS AND VARNISHES, PREPREGS AND LAMINATES MADE THEREFORM ISOLA USA CORP. (US) 2013-07-25 WO claimed
EP-2101585-A1 DIALKYLAMINO ALKYL ESTERS OF PIVAGABINE AS MEDICAMENTS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS Cenerx Biopharma, Inc. (US) 2009-09-23 EP claimed
US-20090111813-A1 Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders CENERX BIOPHARMA, INC. (US) 2009-04-30 US claimed
WO-2008066874-A1 DIALKYLAMINO ALKYL ESTERS OF PIVAGABINE AS MEDICAMENTS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS CENERX BIOPHARMA, INC. (US) 2008-06-05 WO claimed
US-4954571-A RUBBER AND COPOLYMERIZED STYRENE-TYPE, ACRYLONITRILE-TYPE, MALEIMIDE-TYPE MONOMER; MOLDING MATRIAL FOR ELECTRIC APPLIANCES, ELECTRONIC EQUIPMENT AND CARS MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1990-09-04 US claimed
WO-2025214886-A1 HETEROBIFUNCTIONAL LINKER ETH ZURICH (CH) 2025-10-16 WO disclosed
EP-4606856-A1 RESIN COMPOSITION LG Chem, Ltd. (KR) 2025-08-27 EP disclosed
CN-119654375-A Resin composition 株式会社LG化学 2025-03-18 CN disclosed
CN-114432301-B Covalent inhibitor derivative and application thereof in treatment of viral infection 北京大学 2024-05-31 CN disclosed
WO-1995029912-A1 ERGOLINE DERIVATIVES AS ANALGESICS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-11-09 WO disclosed
EP-0435503-A1 Improvements in or relating to gylcopeptide derivatives ELI LILLY AND COMPANY (US) 1991-07-03 EP disclosed
US-4250063-A COORDINATION CATALYST COMPRISING AN ORGANIC COMPLEX OF TUNGSTEN OR MOLYBDENUM, A TITANIUM TETRAHALIDE, AND AN N-HALO IMIDE, A SULFIDE, A SULFOXIDE, OR A PHOSPHINE; POLYALKENAMERS JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1981-02-10 US disclosed
US-4237254-A USING A SOLID CATALYST OF ORGANOALUMINUM COMPONENT, MAGNESIUM HYDROXYHALIDE, A CARBOXYLIC ESTER AND A TITANIUM HALIDE MITSUBISHI PETROCHEMICAL COMPANY LIMITED (JP) 1980-12-02 US disclosed